Agenda Details

Learn more about sessions and presentations at the 25th Annual Meeting

Detailed Program

Considerations for GT Development in Diseases with Available Therapies

Jill Jarecki, PhD. BioMarin, CureSMA, CA

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.